Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Why Fast-paced Mover BrightSpring Health Services, Inc. (BTSG) Is a Great Choice for Value Investors
Why Fast-paced Mover BrightSpring Health Services, Inc. (BTSG) Is a Great Choice for Value Investors

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that

Despite Fast-paced Momentum, Community Health Systems (CYH) Is Still a Bargain Stock
Despite Fast-paced Momentum, Community Health Systems (CYH) Is Still a Bargain Stock

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks

Here's Why Momentum in Liquidity Services (LQDT) Should Keep going
Here's Why Momentum in Liquidity Services (LQDT) Should Keep going

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure

Recent Price Trend in Aura Minerals (AUGO) is Your Friend, Here's Why
Recent Price Trend in Aura Minerals (AUGO) is Your Friend, Here's Why

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure

RDN Stock Trading at a Discount to Industry at 0.98X: Time to Buy?
RDN Stock Trading at a Discount to Industry at 0.98X: Time to Buy?

Radian Group Inc.’s RDN shares are trading at a discount compared with the Zacks Multi-line Insurance industry. Its forward price-to-book value of 0.98X is lower than the industry average of 2.33X

VOYA Stock Trading at a Discount to Industry at 0.98X: Time to Buy?
VOYA Stock Trading at a Discount to Industry at 0.98X: Time to Buy?

Voya Financial, Inc.’s VOYA shares are trading at a discount compared with the Zacks Life Insurance industry. Its forward price-to-book value of 0.94X is lower than the industry average of 1.81X

Flowserve and Bassett Furniture have been highlighted as Zacks Bull and Bear of the Day
Flowserve and Bassett Furniture have been highlighted as Zacks Bull and Bear of the Day

For Immediate Release

Chicago, IL – March 4, 2026 – Zacks Equity Research shares Flowserve Corp. FLS as the Bull of the Day and Bassett Furniture Industries, Inc. BSET as the Bear of the Day. In

3 Major Regional Banks to Bet on Amid Favorable Industry Tailwinds
3 Major Regional Banks to Bet on Amid Favorable Industry Tailwinds
The Zacks Major Regional Banks’ asset quality is expected to remain weak in the near term due to the challenging operating backdrop. Yet, as the Federal Reserve lowers interest rates, industry
Advanced Flower Capital Inc. (AFCG) Reports Q4 Loss, Lags Revenue Estimates
Advanced Flower Capital Inc. (AFCG) Reports Q4 Loss, Lags Revenue Estimates

Advanced Flower Capital Inc. (AFCG) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.29 per share a year ago

Abercrombie & Fitch (ANF) Surpasses Q4 Earnings and Revenue Estimates
Abercrombie & Fitch (ANF) Surpasses Q4 Earnings and Revenue Estimates

Abercrombie & Fitch (ANF) came out with quarterly earnings of $3.68 per share, beating the Zacks Consensus Estimate of $3.56 per share. This compares to earnings of $3.57 per share a year ago. These

3 Top-Ranked Vanguard Mutual Funds You Should Consider Buying
3 Top-Ranked Vanguard Mutual Funds You Should Consider Buying

Vanguard, one of the world’s largest asset management corporations, was founded by John C. Bogle on May 1, 1975. Headquartered in Valley Forge, PN, the company had $11 trillion in assets under

Holley Inc. (HLLY) Misses Q4 Earnings Estimates
Holley Inc. (HLLY) Misses Q4 Earnings Estimates

Holley Inc. (HLLY) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.11 per share a year ago. These

Daktronics (DAKT) Misses Q3 Earnings Estimates
Daktronics (DAKT) Misses Q3 Earnings Estimates

Daktronics (DAKT) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.01 per share a year ago. These figures

New Strong Sell Stocks for March 4th
New Strong Sell Stocks for March 4th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

BKV Corporation BKV is an energy company, which produce natural gas from its owned and operated upstream businesses. The

JD Gears Up to Report Q4 Earnings: What's in Store for the Stock?
JD Gears Up to Report Q4 Earnings: What's in Store for the Stock?

JD.com JD is scheduled to release fourth-quarter 2025 results on March 5.The Zacks Consensus Estimate for JD’s fourth-quarter revenues is pegged at $50.22 billion, indicating an increase of 5.64% on

Here's How Much You'd Have If You Invested $1000 in Fair Isaac a Decade Ago
Here's How Much You'd Have If You Invested $1000 in Fair Isaac a Decade Ago

For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and

Here's How Much a $1000 Investment in HubSpot Made 10 Years Ago Would Be Worth Today
Here's How Much a $1000 Investment in HubSpot Made 10 Years Ago Would Be Worth Today

For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and

If You Invested $1000 in ATI a Decade Ago, This is How Much It'd Be Worth Now
If You Invested $1000 in ATI a Decade Ago, This is How Much It'd Be Worth Now

How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across

Chewy Expands Pet Health Platform: Is CHWY a Long-Term Play?
Chewy Expands Pet Health Platform: Is CHWY a Long-Term Play?

Chewy, Inc. CHWY built its brand as a pure-play pet e-commerce platform spanning food, treats, supplies and medications. Now the company is pushing deeper into pet health and services that can lift

Will Petrobras Pull Off Q4 Earnings Beat on Strong Production?
Will Petrobras Pull Off Q4 Earnings Beat on Strong Production?

Petroleo Brasileiro S.A., or Petrobras PBR, is set to release fourth-quarter 2025 results on March 5. The Zacks Consensus Estimate for the to-be-reported quarter is a profit of 57 cents per share on

Why Home Depot Expects Second Half Comps to Outperform First Half
Why Home Depot Expects Second Half Comps to Outperform First Half

The Home Depot, Inc. HD expects comparable sales growth in fiscal 2026 to be stronger in the second half than in the first half. Management expects comparable sales to be flat to up 2% for the

Dycom Industries (DY) Q4 Earnings and Revenues Surpass Estimates
Dycom Industries (DY) Q4 Earnings and Revenues Surpass Estimates

Dycom Industries (DY) came out with quarterly earnings of $2.03 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $1.17 per share a year ago. These

EyePoint (EYPT) Reports Q4 Loss, Tops Revenue Estimates
EyePoint (EYPT) Reports Q4 Loss, Tops Revenue Estimates

EyePoint (EYPT) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.78. This compares to a loss of $0.64 per share a year ago. These figures are

D-Wave Quantum's Q4 Bookings Fall Y/Y: How Does the Year Ahead Look?
D-Wave Quantum's Q4 Bookings Fall Y/Y: How Does the Year Ahead Look?

D-Wave Quantum QBTS reported bookings of $13.4 million in the fourth quarter of 2025, down 27% compared to the prior-year period, which benefited from an eight-figure system sale. On a sequential

TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Misses Revenue Estimates
TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Misses Revenue Estimates

TScan Therapeutics, Inc. (TCRX) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.29 per share a year ago. These